These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5231945)

  • 21. [Radiology in the clinical and therapeutic evolution of Hodgkin's disease].
    Lucchi A; Montanelli C; De Florio L; Vecchi V
    Radiol Med; 1979 May; 65(5):325-6. PubMed ID: 549110
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
    Andrieu JM; Asselain B; Bayle C; Teillet F; Clot P; Dana M; Katz M; Brière J; Jacquillat C; Bernard J
    Bull Cancer; 1981; 68(2):190-9. PubMed ID: 7016225
    [No Abstract]   [Full Text] [Related]  

  • 23. [Extended irradiation in Hodgkin's disease. Early reactions].
    Tubiana M; Rambert P; Laugier A; Lalanne CM
    Nouv Rev Fr Hematol; 1966; 6(1):164-74. PubMed ID: 4222299
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
    Sutcliffe SB; Economopoulos T; Wrigley PF; Stansfeld AG; Malpas JS
    Clin Oncol; 1980 Dec; 6(4):329-36. PubMed ID: 6161731
    [No Abstract]   [Full Text] [Related]  

  • 25. Hodgkin's disease: treatment with low dose radiation and chemotherapy.
    Donaldson SS
    Front Radiat Ther Oncol; 1981; 16():122-33. PubMed ID: 7333475
    [No Abstract]   [Full Text] [Related]  

  • 26. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hodgkin's disease: a retrospective analysis of 15 years experience at a large referral centre.
    Chandi L; Kumar L; Kochupillai V; Dawar R; Singh R
    Natl Med J India; 1998; 11(5):212-7. PubMed ID: 10997167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary treatment of Hodgkin's disease with sequential radiation therapy and multidrug chemotherapy without initial laparotomy--splenectomy.
    Lacher MJ
    Prog Clin Cancer; 1982; 8():283-97. PubMed ID: 7156405
    [No Abstract]   [Full Text] [Related]  

  • 29. The course and the results of treatment in Hodgkin's disease.
    Durkovský J; Jancina J; Kuzma I
    Neoplasma; 1967; 14(1):91-104. PubMed ID: 6031833
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hodgkin's disease: treatment specificities in childhood].
    Claude L; Schell M
    Cancer Radiother; 2009 Oct; 13(6-7):527-9. PubMed ID: 19783192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non-gonadic complications of chemoradiotherapy in Hodgkin's disease. A study of eighty-three patients (author's transl)].
    Bolla M; Sotto JJ; Barjhoux R; Kolodie H; Vincent F; Michallet M; Sarrazin R; Vrousos C; Hollard D
    Sem Hop; 1982 Jan; 58(4):204-8. PubMed ID: 6280286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of malignant lymphomas].
    Huber H; Gattringer C; Lechleitner M; Gyenes T; Frommhold H; Brittinger G; Braunsteiner H
    Wien Klin Wochenschr; 1983 Feb; 95(4):93-112. PubMed ID: 6342274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hodgkin's disease in childhood: therapy results in Argentina.
    Sackmann-Muriel F; Bonesana AC; Pavlovsky S; Papendieck C; Morgenfeld M; Penchansky L; Schwartz L; Kvicala R; Sica M; Ojeda F
    Am J Pediatr Hematol Oncol; 1981; 3(3):247-54. PubMed ID: 7025683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.
    Coltman CA; Dixon DO
    Cancer Treat Rep; 1982 Apr; 66(4):1023-33. PubMed ID: 7074630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of betamethasone in polychemotherapy of lymphoproliferative diseases].
    Cellerino R; Ambrosetti A; Tummarello D; Perini A; Piga A; Celebrano M
    Minerva Med; 1980 Sep; 71(32):2293-7. PubMed ID: 6933321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukaemia of the myeloid series in patients with Hodgkin's disease.
    Stenfert Kroese WF; Sizoo W; Somers R
    Neth J Med; 1976; 19(4-5):234-8. PubMed ID: 1068348
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.